ACADIA Pharmaceuticals Shares Outstanding 2006-2019 | ACAD

ACADIA Pharmaceuticals shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ACADIA Pharmaceuticals shares outstanding for the quarter ending September 30, 2019 were 0.146B, a 16.72% increase year-over-year.
  • ACADIA Pharmaceuticals 2018 shares outstanding were 0.127B, a 3.25% increase from 2017.
  • ACADIA Pharmaceuticals 2017 shares outstanding were 0.123B, a 5.82% increase from 2016.
  • ACADIA Pharmaceuticals 2016 shares outstanding were 0.116B, a 15.13% increase from 2015.
ACADIA Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 127
2017 123
2016 116
2015 101
2014 97
2013 86
2012 55
2011 52
2010 39
2009 37
2008 37
2007 35
2006 28
2005 22
ACADIA Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 146
Q2 2019 144
Q1 2019 144
Q4 2018 127
Q3 2018 125
Q2 2018 125
Q1 2018 125
Q4 2017 123
Q3 2017 122
Q2 2017 122
Q1 2017 122
Q4 2016 116
Q3 2016 117
Q2 2016 113
Q1 2016 111
Q4 2015 101
Q3 2015 101
Q2 2015 100
Q1 2015 100
Q4 2014 97
Q3 2014 99
Q2 2014 99
Q1 2014 93
Q4 2013 86
Q3 2013 90
Q2 2013 83
Q1 2013 79
Q4 2012 55
Q3 2012 54
Q2 2012 53
Q1 2012 53
Q4 2011 52
Q3 2011 53
Q2 2011 53
Q1 2011 50
Q4 2010 39
Q3 2010 38
Q2 2010 38
Q1 2010 38
Q4 2009 37
Q3 2009 37
Q2 2009 37
Q1 2009 37
Q4 2008 37
Q3 2008 37
Q2 2008 37
Q1 2008 37
Q4 2007 35
Q3 2007 37
Q2 2007 37
Q1 2007 30
Q4 2006 28
Q3 2006 30
Q2 2006 28
Q1 2006 24
Q4 2005 22
Q3 2005 23
Q2 2005 23
Q1 2005 18
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.321B $0.224B
Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.367B 15.59
Gilead Sciences (GILD) United States $83.158B 10.30
CSL (CSLLY) Australia $82.719B 0.00
Vertex Pharmaceuticals (VRTX) United States $55.416B 56.56
Biogen (BIIB) United States $52.050B 8.93
Illumina (ILMN) United States $45.989B 50.46
Regeneron Pharmaceuticals (REGN) United States $38.514B 16.86
Alexion Pharmaceuticals (ALXN) United States $24.238B 11.97
Seattle Genetics (SGEN) United States $20.549B 0.00
Incyte (INCY) United States $19.041B 44.20
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.844B 0.00
Genmab (GNMSF) Denmark $13.732B 60.65
Alnylam Pharmaceuticals (ALNY) United States $12.398B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Galapagos (GLPG) Belgium $10.266B 26.45
Exact Sciences (EXAS) United States $10.259B 0.00
BeiGene (BGNE) Cayman Islands $10.005B 0.00
QIAGEN (QGEN) Netherlands $9.248B 30.15
Bio-Techne Corp (TECH) United States $8.182B 54.77
Sarepta Therapeutics (SRPT) United States $7.765B 0.00
Guardant Health (GH) United States $7.403B 0.00
Amarin (AMRN) Ireland $7.330B 0.00
Moderna (MRNA) United States $6.732B 0.00
Reata Pharmaceuticals (RETA) United States $6.196B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.806B 14.76
Medicines (MDCO) United States $5.562B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.462B 0.00
Exelixis (EXEL) United States $4.968B 13.97
Ascendis Pharma (ASND) Denmark $4.797B 0.00
China Biologic Products (CBPO) China $4.577B 25.78
Repligen (RGEN) United States $4.388B 79.52
Spark Therapeutics (ONCE) United States $4.297B 0.00
Bluebird Bio (BLUE) United States $4.077B 0.00
Blueprint Medicines (BPMC) United States $3.787B 0.00
MorphoSys AG (MOR) Germany $3.631B 0.00
Immunomedics (IMMU) United States $3.558B 0.00
Mirati Therapeutics (MRTX) United States $3.511B 0.00
Adaptive Biotechnologies (ADPT) United States $3.464B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.279B 0.00
Alkermes (ALKS) Ireland $3.163B 0.00
Genmab (GMAB) Denmark $2.899B 5.97
Intercept Pharmaceuticals (ICPT) United States $2.877B 0.00
Halozyme Therapeutics (HALO) United States $2.780B 0.00
Emergent Biosolutions (EBS) United States $2.706B 26.88
MyoKardia (MYOK) United States $2.681B 0.00
NeoGenomics (NEO) United States $2.561B 136.28
Amicus Therapeutics (FOLD) United States $2.411B 0.00
Arena Pharmaceuticals (ARNA) United States $2.350B 5.47
Acceleron Pharma (XLRN) United States $2.315B 0.00
Zai Lab (ZLAB) China $2.236B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.220B 0.00
UniQure (QURE) Netherlands $2.219B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Cambrex (CBM) United States $2.021B 25.50
Ligand Pharmaceuticals (LGND) United States $1.916B 36.86
Myriad Genetics (MYGN) United States $1.868B 27.59
Insmed (INSM) United States $1.867B 0.00
Akcea Therapeutics (AKCA) United States $1.815B 0.00
Denali Therapeutics (DNLI) United States $1.631B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.580B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.535B 0.00
Epizyme (EPZM) United States $1.511B 0.00
Zymeworks (ZYME) Canada $1.508B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.481B 0.00
REGENXBIO (RGNX) United States $1.385B 0.00
Coherus BioSciences (CHRS) United States $1.297B 0.00
Innoviva (INVA) United States $1.275B 3.76
Editas Medicine (EDIT) United States $1.252B 0.00
Athenex (ATNX) United States $1.195B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Arvinas (ARVN) United States $1.171B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Fate Therapeutics (FATE) United States $1.094B 0.00
Alector (ALEC) United States $1.091B 0.00
WAVE Life Sciences (WVE) Singapore $1.040B 0.00
Principia Biopharma (PRNB) United States $1.019B 0.00
Zealand Pharma (ZEAL) Denmark $0.979B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.976B 0.00
Cara Therapeutics (CARA) United States $0.933B 0.00
Codexis (CDXS) United States $0.901B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.860B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.836B 7.03
ZIOPHARM Oncology Inc (ZIOP) United States $0.831B 0.00
Anika Therapeutics (ANIK) United States $0.831B 26.96
Vericel (VCEL) United States $0.824B 307.33
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Twist Bioscience (TWST) United States $0.746B 0.00
Intellia Therapeutics (NTLA) United States $0.740B 0.00
Revance Therapeutics (RVNC) United States $0.738B 0.00
Heska (HSKA) United States $0.722B 184.36
ANI Pharmaceuticals (ANIP) United States $0.694B 11.83
MiMedx (MDXG) United States $0.677B 0.00
DBV Technologies S.A (DBVT) France $0.659B 0.00
Adverum Biotechnologies (ADVM) United States $0.631B 0.00
Precision BioSciences (DTIL) United States $0.620B 0.00
Mesoblast (MESO) Australia $0.605B 0.00
UROGEN PHARMA (URGN) United States $0.604B 0.00
Retrophin (RTRX) United States $0.579B 0.00
GENFIT S.A (GNFT) France $0.575B 0.00
Cellectis S.A (CLLS) France $0.564B 0.00
Agenus (AGEN) United States $0.563B 0.00
Cytokineticsorporated (CYTK) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.556B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.539B 0.00
Stemline Therapeutics (STML) United States $0.525B 0.00
Intra-Cellular Therapies (ITCI) United States $0.524B 0.00
Kadmon Holdings (KDMN) United States $0.517B 0.00
AC Immune SA (ACIU) Switzerland $0.503B 11.63
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
PHARMA MAR SA (PHMMF) Spain $0.487B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Dynavax Technologies (DVAX) United States $0.452B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.433B 2.99
Clovis Oncology (CLVS) United States $0.425B 0.00
Bellus Health (BLU) Canada $0.375B 0.00
Arcus Biosciences (RCUS) United States $0.366B 0.00
PDL BioPharma (PDLI) United States $0.356B 8.91
Merus (MRUS) Netherlands $0.349B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
Puma Biotechnology (PBYI) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.334B 0.00
Starpharma Holdings (SPHRY) Australia $0.333B 0.00
AnaptysBio (ANAB) United States $0.322B 0.00
Gritstone Oncology (GRTS) United States $0.319B 0.00
Compugen (CGEN) Israel $0.293B 0.00
Kindred Biosciences (KIN) United States $0.290B 0.00
Avid Bioservices (CDMO) United States $0.290B 0.00
Pfenex (PFNX) United States $0.290B 0.00
Scholar Rock Holding (SRRK) United States $0.280B 0.00
Protagonist Therapeutics (PTGX) United States $0.276B 0.00
Kamada (KMDA) Israel $0.275B 8.04
OSMOTICA PHARM (OSMT) United States $0.270B 0.00
Geron (GERN) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Cel-Sci (CVM) United States $0.265B 0.00
CytomX Therapeutics (CTMX) United States $0.261B 0.00
Inovio Pharmaceuticals (INO) United States $0.250B 0.00
Theratechnologies (THTX) Canada $0.246B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.244B 0.00
Albireo Pharma (ALBO) United States $0.244B 0.00
MannKind (MNKD) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.243B 0.00
Sutro Biopharma (STRO) United States $0.243B 0.00
Cue Biopharma (CUE) United States $0.229B 0.00
Biofrontera AG (BFRA) Germany $0.223B 0.00
ChromaDex (CDXC) United States $0.216B 0.00
Athersys (ATHX) United States $0.216B 0.00
Sorrento Therapeutics (SRNE) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.212B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
Exicure (XCUR) United States $0.201B 0.00
Syros Pharmaceuticals (SYRS) United States $0.199B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.197B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.191B 0.00
Palatin Technologies (PTN) United States $0.186B 5.06
Senesco Technologies (ELOX) United States $0.184B 0.00
Affimed (AFMD) Germany $0.180B 0.00
Arsanis (XFOR) United States $0.168B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.160B 0.00
Dyadic (DYAI) United States $0.156B 0.00
Mersana Therapeutics (MRSN) United States $0.155B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.153B 0.00
Alcobra (ARCT) United States $0.145B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.134B 0.00
Ophthotech (ISEE) United States $0.134B 0.00
Enzo Biochem (ENZ) United States $0.133B 0.00
BioTime (LCTX) United States $0.132B 6.77
Cerecor (CERC) United States $0.131B 0.00
Nicox SA (NICXF) France $0.128B 0.00
Abeona Therapeutics (ABEO) United States $0.124B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Five Prime Therapeutics (FPRX) United States $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.117B 0.00
NantKwest (NK) United States $0.116B 0.00
Emmaus Life Sciences (EMMA) United States $0.114B 0.00
ARAVIVE, INC (ARAV) United States $0.113B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
OvaScience (MLND) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.109B 0.00
Aptinyx (APTX) United States $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Novavax (NVAX) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.098B 0.00
PHASEBIO PHARMA (PHAS) United States $0.098B 0.00
Menlo Therapeutics (MNLO) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aduro Biotech (ADRO) United States $0.085B 0.00
Arbutus Biopharma (ABUS) Canada $0.085B 0.00
Acorda Therapeutics (ACOR) United States $0.083B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Strongbridge Biopharma (SBBP) United States $0.081B 2.16
Proteostasis Therapeutics (PTI) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Verastem (VSTM) United States $0.067B 0.00
Selecta Biosciences (SELB) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Trevena (TRVN) United States $0.058B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Curis (CRIS) United States $0.055B 0.00
Orgenesis (ORGS) United States $0.054B 3.49
Idera Pharmaceuticals (IDRA) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Checkpoint Therapeutics (CKPT) United States $0.052B 0.00
Pluristem Therapeutics (PSTI) Israel $0.051B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.046B 0.00
Novogen (KZIA) Australia $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
DiaMedica Therapeutics (DMAC) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Evogene (EVGN) Israel $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Celsion (CLSN) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
VistaGen Therapeutics (VTGN) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00